Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically Defined Diseases

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Maze Announces $190M Financing to Support Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically Defined Diseases

Click to view original post